@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-P8DSGL9F-4 skos:prefLabel "Sulfanilamides"@en, "Sulfamides"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-HL1PK78C-M . jvr:-GZXH27B4-B skos:prefLabel "Anti-infectieux"@fr, "Anti-Infective Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HL1PK78C-M mesh:allowableQualifier jvr:-Q3979798-W, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-TJHVZCRZ-0, jvr:-THHNVC7V-3, jvr:-S0CS1X5R-5, jvr:-G4R176S9-J, jvr:-W6SQV79N-S, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-L6C0XPHT-4, jvr:-M63HSDM7-1, jvr:-FWD2BGQ0-9, jvr:-G30ZJ446-J, jvr:-NHL3D2X0-S, jvr:-NB0XHT3S-N, jvr:-BT300B3G-Q, jvr:-CB30NGKB-3, jvr:-HQRFT0C6-B, jvr:-R0ZCQ8X6-J, jvr:-H7K65Q8S-Z ; skos:hiddenLabel "Sulfisoxazole, Triammonium Salt"@en, "Sulfisoxazole, Ammonium Salt"@en, "Sulfisoxazole, Monosodium Salt"@en, "Gantrisin"@en, "Gantrisin Pediatric"@en, "Sulfisoxazole, Monosodium, Monomesylate Salt"@en, "Neoxazoi"@en, "Sulfisoxazole Diolamine"@en, "V-Sul"@en, "TL-azole"@en, "Sulfisoxazole, Monolithium Salt"@en, "Sulfafurazol FNA"@en ; skos:prefLabel "Sulfisoxazole"@en, "Sulfafurazol"@fr ; a skos:Concept, mesh:Descriptor ; skos:altLabel "76849-49-5 (tri-NH4 salt)"@fr, "76849-49-5 (tri-NH4 salt)"@en, "Sulfafurazole"@en, "35915-70-9 (mono-Na, monomesylate salt)"@fr, "35915-70-9 (mono-Na, monomesylate salt)"@en, "Sulfadimethyloxazole"@en, "Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-"@fr, "Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-"@en, "6155-81-3 (mono-Li salt)"@fr, "6155-81-3 (mono-Li salt)"@en, "4299-60-9 (Sulfisoxazole Diolamine)"@en, "4299-60-9 (Sulfisoxazole Diolamine)"@fr, "76849-50-8 (mono-NH4 salt)"@fr, "76849-50-8 (mono-NH4 salt)"@en, "2200-44-4 (mono-Na salt)"@fr, "2200-44-4 (mono-Na salt)"@en, "30S4B46J8B"@fr, "30S4B46J8B"@en, "Sulfasoxizole"@en, "740T4C525W"@fr, "740T4C525W"@en, "127-69-5 (Sulfisoxazole)"@fr, "127-69-5 (Sulfisoxazole)"@en ; mesh:pharmacologicalAction jvr:-GZXH27B4-B ; skos:broader jvr:-P8DSGL9F-4 ; skos:inScheme jvr: ; skos:definition "A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms."@en ; dc:modified "2016-07-01"^^xsd:date ; dc:established "1966-01-01"^^xsd:date ; owl:sameAs ; dc:created "1999-01-01"^^xsd:date . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .